Memory loss from Alzheimer's disease is notoriously difficult to treat. Every promising new medicine has been met with disappointing results after launch. Eisai's newly launched Lecanemab has proven to slow the debilitating disease, and offer those who suffer from it some very valuable time to both create and enjoy entirely new memories.